{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-038015","form_type":"8-K","ticker":"KALV","cik":"0001348911","company_name":"KalVista Pharmaceuticals, Inc.","filed_at":"2025-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.407703+00:00","generated_at":"2026-05-24T22:08:49.337875+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"KalVista Q3 fiscal 2025: $253.2M cash, sebetralstat regulatory progress; PDUFA June 17","bullets":["No revenue; R&D expense $12.6M (down from $22.5M YoY); G&A $30.3M (up from $10.6M) due to pre-commercial activities.","Cash, cash equivalents and marketable securities of $253.2M as of Jan 31, 2025.","Sebetralstat NDA submitted in Japan, orphan drug designation granted; U.S. PDUFA date June 17, 2025.","Raised $160M gross proceeds in Nov 2024 via synthetic royalty financing and equity offerings to fund launch.","Field sales team onboarded; Jeb Ledell appointed COO; new data presented on laryngeal attacks, adolescents, and LTP patients."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-038015","json":"https://secwatch.observer/filing/0000950170-25-038015.json","markdown":"https://secwatch.observer/filing/0000950170-25-038015.md","text":"https://secwatch.observer/filing/0000950170-25-038015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348911/000095017025038015/0000950170-25-038015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348911/000095017025038015/kalv-20250312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T22:08:49.337875+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}